Arca Biopharma Inc.





Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 0.60
Prev. Close: 0.57
Low/Hi: 0.56 - 0.60
52-Week: 0.45 - 2.50
Equity: 91,095
90-Day Avg: 607,432
Todays Stock Vol: 81.9
20-Day (HV): 85.4
52-Week (HV): 105.3
Div. Yield:
Earnings: 7-Aug (Est.)
P/E Ratio:
Market Cap: 8.0 M
Short Int Pct: 0.0%
Pct Held By Inst.: 33.1%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ABIO

ARCA biopharma, Inc is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate, Gencaroâ„¢ (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that is in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and left ventricular systolic dysfunction, or HFREF.
Primary Exchange: NASDAQ
SIC In Vitro & In Vivo Diagnostic Substances
NAICS In-Vitro Diagnostic Substance Manufacturing

ABIO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 14.9 B 1.49391E+10 3,452 3452 0.0% 0 495 495
WMCR Invesco Wilshire Micro-Cap ETF 29.9 M 2.99E+07 978 978 0.01% 7E-05 2 K 1990

Wait, Before You Leave...